doi:10.1007/s12250-014-3504-0

[1]
Yange Niu, Ye Liu, Limin Yang, Hongren Qu, Jingyi Zhao, Rongliang Hu, Jing Li, Wenjun Liu, 2016: Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies, Virologica Sinica, 31, 168-175. doi: 10.1007/s12250-016-3734-4
[2]
Guo-zhen LIN, Fu-ying ZHENG, Ji-zhang ZHOU, Xiao-an CAO, Xiao-wei GONG, Guang-hua WANG, Chang-qing QIU, 2010: An Indirect ELISA of Classical Swine Fever Virus Based on Quadruple Antigenic Epitope Peptide Expressed in E.coli, Virologica Sinica, 25, 71-76. doi: 10.1007/s12250-010-3086-4
[3]
Xianmiao Ye, Junnan Lu, Zirong Han, Zhishan Fan, Xinru Hu, Lichuang Jiao, Lisha Deng, Wenming Liu, Junqi Liu, Weiqi Pan, Ling Chen, Liqiang Feng, Caijun Sun, 2026: A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses, Virologica Sinica, 41, 423-438. doi: 10.1016/j.virs.2026.04.004
[4]
Hao Chen, Rui Zhu, Yuanyuan Wu, Zhifeng Ke, Yubo Wu, Dongqing Zhang, Yuxiang Zou, Jiaying Wu, Xuejun Feng, Zhichao Yin, Mujin Fang, Ningshao Xia, Longfa Xu, Tong Cheng, 2025: A dual monoclonal antibody-based sandwich ELISA for detection of potent vaccine immunogen against Coxsackievirus B1, Virologica Sinica, 40, 1050-1053. doi: 10.1016/j.virs.2025.11.007
[5]
Dan Zang, Wuchang Heng, Ruiyu Li, Chenxi Wei, Ruibin Qi, Getachew Mulatu Dilba, Jiasen Liu, Qian Jiang, Honglin Jia, Hongtao Kang, 2026: Feline calicivirus VP1-based mRNA vaccine protects cats against FCV challenge, Virologica Sinica, 41, 482-484. doi: 10.1016/j.virs.2026.03.010
[6]
Rong-Rong Zhang, Meng-Jiao He, Chao Zhou, Yan-Peng Xu, Wei Tang, Tian-Shu Cao, Zheng-Jian Wang, Mei Wu, Tao Ming, Yi-Jiao Huang, Meng-Xu Sun, Hui Zhao, Yong-Qiang Deng, Xiao-Feng Li, Bin Wang, Qing Ye, Cheng-Feng Qin, 2024: Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71, Virologica Sinica, 39, 812-820. doi: 10.1016/j.virs.2024.09.008
[7]
Kaissar Tabynov, Zhailaubai Kydyrbayev, Abylai Sansyzbay, Berik Khairullin, Sholpan Ryskeldinova, Nurika Assanzhanova, Yerken Kozhamkulov, Dulat Inkarbekov, 2012: Immunogenic and Protective Properties of the First Kazakhstan Vaccine against Pandemic Influenza A(H1N1) pdm09 in Ferrets, Virologica Sinica, 27, 345-352. doi: 10.1007/s12250-012-3272-7
[8]
严家新, 黄鹤, 潘南胜, 姚洁, 1992: Estimation of the Rates of Haemagglutinin Mutation of Influenza A Viruses Isolated in Recent years Using the 125 I-Iabeled Peptide Mapping, Virologica Sinica, 7, 149-.
[9]
Xiaohong Xu, Jing Qian, Lingsong Qin, Jindou Li, Cong Xue, Jiaxin Ding, Weiqi Wang, Wei Ding, Renfu Yin, Ningyi Jin, Zhuang Ding, 2020: Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge, Virologica Sinica, 35, 455-467. doi: 10.1007/s12250-020-00199-1
[10]
Jun-jun Shao, Jing-feng Wang, Hui-yun Chang, Ji-xing Liu, 2011: Immune Potential of a Novel Multiple-epitope Vaccine to FMDV Type Asia 1 in Guinea Pigs and Sheep, Virologica Sinica, 26, 190-197. doi: 10.1007/s12250-011-3174-0
[11]
王玉珍, 张晓华, 戴和平, , , 2006: Construction of a Phage Display Random Decapeptide Library and Panning for Mimic Antigen Epitope of ScFv A1 Against WSSV, Virologica Sinica, 21, 614-618.
[12]
Hui FENG, Kang-hong HU, 2008: Aptamers Against Viral Hepatitis: from Rational Design to Practical Application^*, Virologica Sinica, 23, 315-320. doi: 10.1007/s12250-008-2979-y
[13]
Zimin Xie, Yingyi Chen, Shanyao Du, Xiumei Huang, Yuhuan Shao, Jiangwu Huang, Ming Liao, Manman Dai, 2026: HVT-based multiepitope vaccine administered subcutaneously or in ovo boosts protection of inactivated H9N2 vaccine against heterologous virus, Virologica Sinica, 41, 455-465. doi: 10.1016/j.virs.2026.04.008
[14]
Jinliang Liu, Shiyu Dai, Manli Wang, Zhihong Hu, Hualin Wang, Fei Deng, 2016: Virus like particle-based vaccines against emerging infectious disease viruses, Virologica Sinica, 31, 279-287. doi: 10.1007/s12250-016-3756-y
[15]
龚镇奎, 韦浩春, 王莉, 徐又龙, 骆林, 詹发先, 彭世勇, 1992: Antiviral Activities of "Antipyretic 1" Oral Liquor against Four Kinds of Viruses, Virologica Sinica, 7, 32-.
[16]
Liang-Jun Chen, Jing-Jing Guo, Wei-Wei Guo, E-Xiang Shen, Xin Wang, Kai-Ji Li, Jie Yan, Mang Shi, Yi-Rong Li, Wei Hou, 2020: Molecular Epidemiology and Vaccine Compatibility Analysis of Seasonal Influenza Viruses in Wuhan, 2016–2019, Virologica Sinica, 35, 556-565. doi: 10.1007/s12250-020-00225-2
[17]
Jiu-ru Zhao, Yong-dong Li, Li-min Pan, Na Zhu, Hong-xia Ni, Guo-zhang Xu, Yong-zhong Jiang, Xi-xiang Huo, Jun-qiang Xu, Han Xia, Na Han, Shuang Tang, Zhong Zhang, Zheng Kou, Simon Rayner, Tian-xian Li, 2011: Genetic Characteristics of 2009 Pandemic H1N1 Influenza A Viruses Isolated from Mainland China ^*, Virologica Sinica, 26, 418-427. doi: 10.1007/s12250-011-3228-3
[18]
Zhaomin Feng, Wenfei Zhu, Lei Yang, Jia Liu, Lijuan Zhou, Dayan Wang, Yuelong Shu, 2021: Epidemiology and Genotypic Diversity of Eurasian Avian-Like H1N1 Swine Influenza Viruses in China, Virologica Sinica, 36, 43-51. doi: 10.1007/s12250-020-00257-8
[19]
Lei Deng, Jia-Ye Liu, Ya-Xuan Peng, 2026: Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus, Virologica Sinica, 41, 261-275. doi: 10.1016/j.virs.2026.03.011
[20]
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan, Li Ruan, 2019: Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats, Virologica Sinica, 34, 583-591. doi: 10.1007/s12250-019-00138-9